AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19472537 — intervention group
Group type: COMPARATOR
Intervention: Superficial MMC (S‐MMC)
Number of subjects: 25
Study 17574858 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane preconditioning (2.5 minimum alveolar concentration for 5 minutes)
Number of subjects: 28
Study 17574858 — intervention group
Group type: COMPARATOR
Intervention: Control group (desflurane-free bypass for 15 minutes)
Number of subjects: 28
Study 15238031 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentence stems presented in the study phase
Number of subjects: 5
Study 15238031 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentence stems presented in the test phase
Number of subjects: 5
Study 15238031 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentence stems presented in both study and test phases
Number of subjects: 5
Study 15238031 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly constrained terminal words
Number of subjects: 5
Study 15238031 — intervention group
Group type: EXPERIMENTAL
Intervention: Merely consistent terminal words
Number of subjects: 5
Study 15238031 — intervention group
Group type: EXPERIMENTAL
Intervention: Incongruous terminal words
Number of subjects: 5
Study 11903856 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release caffeine (SRC) 300 mg given twice daily (21:00 and 9:00 h) during SD
Number of subjects: 16
Study 11903856 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 16
Study 9477010 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptic treatment
Number of subjects: 30
Study 9477010 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study 8201484 — intervention group
Group type: EXPERIMENTAL
Intervention: Office-based educational intervention (physician advice and written material on cloth and disposable diapers)
Number of subjects: 193
Study 8201484 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital practices (exclusive use of cloth diapers)
Number of subjects: 193
Study 8201484 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 193
Study 3427561 — intervention group
Group type: EXPERIMENTAL
Intervention: Progabide (PGB)
Number of subjects: 32
Study 3427561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 29545635 — intervention group
Group type: EXPERIMENTAL
Intervention: Plecanatide 3 mg
Number of subjects: 2189
Study 29545635 — intervention group
Group type: EXPERIMENTAL
Intervention: Plecanatide 6 mg
Number of subjects: 2189
Study 29545635 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2189
Study 29545635 — intervention group
Group type: EXPERIMENTAL
Intervention: Plecanatide 3 mg and 6 mg
Number of subjects: 2189
Study 27625066 — intervention group
Group type: EXPERIMENTAL
Intervention: Exception to consent process in a paediatric resuscitation trial (SQUEEZE)
Number of subjects: 25
Study 24090176 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized feedback (PF) provided in the context of modified behavioral self‐control therapy
Number of subjects: 90
Study 24090176 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized feedback (PF)
Number of subjects: 90
Study 24090176 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of personalized feedback (PF)
Number of subjects: 90
Study 24090176 — intervention group
Group type: EXPERIMENTAL
Intervention: Other drug risk, family risk, and having an abnormal liver enzyme test result
Number of subjects: 90
Study 22623080 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 90
Study 22623080 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 90
Study 22623080 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketofol
Number of subjects: 90
Study 19945857 — intervention group
Group type: EXPERIMENTAL
Intervention: PTK787/ZK222584 (PTK/ZK) at a dose of 1000 mg once daily in combination with radiotherapy and temozolomide (TMZ)
Number of subjects: 20
Study 19945857 — intervention group
Group type: EXPERIMENTAL
Intervention: PTK787/ZK222584 (PTK/ZK) at a dose of 1250 mg once daily
Number of subjects: 20
Study 19945857 — intervention group
Group type: COMPARATOR
Intervention: Standard adjuvant dose of temozolomide (TMZ)
Number of subjects: 20
Study 19094430 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine pyrophosphate (TPP) 1 mg/kg
Number of subjects: 27
Study 19094430 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 27
Study 15917023 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including opinion leaders, consensus processes, computer-delivered cessation care, computer-generated prompts, staff training, and performance feedback.
Number of subjects: 210
Study 15917023 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 210
Study 15917023 — intervention group
Group type: COMPARATOR
Intervention: Usual cessation care
Number of subjects: 210
Study 12545147 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (20 microg subcutaneously)
Number of subjects: 15
Study 12545147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 14626338 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol combination (FSC) 100/50 or 250/50 microg twice daily
Number of subjects: 686
Study 14626338 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP)
Number of subjects: 686
Study 14626338 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol (SAL)
Number of subjects: 686
Study 10535881 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 85
Study 10535881 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 85
Study 7850943 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiological testing (EPS)
Number of subjects: 286
Study 7850943 — intervention group
Group type: COMPARATOR
Intervention: Holter monitoring (HM)
Number of subjects: 286
Study 2083526 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush
Number of subjects: 19
Study 2083526 — intervention group
Group type: COMPARATOR
Intervention: Chewing stick
Number of subjects: 19
Study 291122 — intervention group
Group type: EXPERIMENTAL
Intervention: RAP + T (daunorubicine, cytarabine, prednisone + thioguanine)
Number of subjects: 194
Study 291122 — intervention group
Group type: COMPARATOR
Intervention: RAP (daunorubicine, cytarabine, prednisone)
Number of subjects: 194
Study 291122 — intervention group
Group type: COMPARATOR
Intervention: RAP
Number of subjects: 194
Study 291122 — intervention group
Group type: EXPERIMENTAL
Intervention: RAP + T
Number of subjects: 194
Study 28418966 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone 0.2 mg/kg at the start of surgery
Number of subjects: 120
Study 26018333 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol (100 µg/d)
Number of subjects: 56
Study 26018333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 26018333 — intervention group
Group type: COMPARATOR
Intervention: Control group (no history of depression)
Number of subjects: 56
Study 22882966 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid group
Number of subjects: 240
Study 22882966 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 240
Study 22059222 — intervention group
Group type: EXPERIMENTAL
Intervention: Group lifestyle support program
Number of subjects: 20
Study 19419306 — intervention group
Group type: EXPERIMENTAL
Intervention: teriparatide treatment (20 microg/d)
Number of subjects: 44
Study 17304653 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0
Study 17304653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17304653 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (no preexisting protective antibody titers)
Number of subjects: 0
Study 17304653 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no preexisting protective antibody titers)
Number of subjects: 0
Study 15549548 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (100 mg/day)
Number of subjects: 0
Study 15549548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11405325 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous hematopoietic malignancy
Number of subjects: 1025
Study 11405325 — intervention group
Group type: EXPERIMENTAL
Intervention: History of hives
Number of subjects: 1025
Study 11405325 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzene exposure > 810 days
Number of subjects: 1025
Study 11405325 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily welding
Number of subjects: 1025
Study 11405325 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity of radio operator
Number of subjects: 1025
Study 11405325 — intervention group
Group type: EXPERIMENTAL
Intervention: Agricultural professional
Number of subjects: 1025
Study 9146256 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline multidisciplinary cultural assessment survey
Number of subjects: 0
Study 9146256 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 7974899 — intervention group
Group type: EXPERIMENTAL
Intervention: Early endocrine therapy
Number of subjects: 0
Study 7974899 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed therapy
Number of subjects: 0
Study 7974899 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 0
Study 7974899 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine therapy plus radical prostatectomy
Number of subjects: 0
Study 2884797 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium (20 micrograms/kg priming dose, 60 micrograms/kg intubating dose)
Number of subjects: 20
Study 2884797 — intervention group
Group type: COMPARATOR
Intervention: Atracurium (100 micrograms/kg priming dose, 300 micrograms/kg intubating dose)
Number of subjects: 20
Study 30594763 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive coping styles
Number of subjects: 568
Study 30594763 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative life events
Number of subjects: 568
Study 30594763 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective Well-being under Neuroleptics-20 (SWN-20) scale
Number of subjects: 568
Study 30594763 — intervention group
Group type: EXPERIMENTAL
Intervention: Utrechtse Coping Lijst (UCL)
Number of subjects: 568
Study 30594763 — intervention group
Group type: EXPERIMENTAL
Intervention: Interview of the Recent Life Event Scale (IRLES)
Number of subjects: 568
Study 28770947 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-epileptic therapy with vitamin B12 (mecobalamin)
Number of subjects: 90
Study 28770947 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-epileptic therapy with compound vitamin B tablets
Number of subjects: 90
Study 28770947 — intervention group
Group type: COMPARATOR
Intervention: Single-agent or combination anti-epileptic therapy with oxcarbazepine and sodium valproate
Number of subjects: 90
Study 25837751 — intervention group
Group type: EXPERIMENTAL
Intervention: PM/Ca (sodium picosulfate, magnesium oxide, and citric acid)
Number of subjects: 209
Study 25837751 — intervention group
Group type: COMPARATOR
Intervention: PEG (polyethylene glycol)
Number of subjects: 209
Study 25837751 — intervention group
Group type: EXPERIMENTAL
Intervention: PM/Ca
Number of subjects: 209
Study 25837751 — intervention group
Group type: COMPARATOR
Intervention: PEG
Number of subjects: 209
Study 23956857 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg of lignocaine hydrochloride
Number of subjects: 114
Study 23956857 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg of dexamethasone
Number of subjects: 114
Study 23956857 — intervention group
Group type: COMPARATOR
Intervention: 5 mL of preservative-free saline
Number of subjects: 114
Study 20689465 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasofoxifene 0.25 mg/day
Number of subjects: 8556
Study 20689465 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasofoxifene 0.5 mg/day
Number of subjects: 8556
Study 20689465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8556
Study 19009227 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplemented bread (1.0 g/day)
Number of subjects: 31
Study 19009227 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplementation
Number of subjects: 31
Study 17530493 — intervention group
Group type: EXPERIMENTAL
Intervention: Stop & Think! program
Number of subjects: 0
Study 17530493 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 15014300 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant administration of Comvax, M‐M‐RII and Varivax
Number of subjects: 822
Study 15014300 — intervention group
Group type: COMPARATOR
Intervention: Nonconcomitant administration of Comvax followed by M‐M‐RII and Varivax 6 weeks later
Number of subjects: 822
Study 11605094 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam 0.25 mg
Number of subjects: 12
Study 11605094 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam 0.5 mg
Number of subjects: 12
Study 11605094 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam 1.0 mg
Number of subjects: 12
Study 11605094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9850204 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50, 100 or 200 mg)
Number of subjects: 178
Study 9850204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study 9850204 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 178
Study 7866474 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 1026
Study 7866474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1026
Study 2479187 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interferon-alpha (0.5 x 10^6 U)
Number of subjects: 72
Study 2479187 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interferon-alpha (1.5 x 10^6 U)
Number of subjects: 72
Study 2479187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 2479187 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interferon-gamma (0.25 x 10^6 IU)
Number of subjects: 72
Study 2479187 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interferon-gamma (1.0 x 10^6 IU)
Number of subjects: 72
Study 775265 — intervention group
Group type: EXPERIMENTAL
Intervention: AN 448 Sandoz (mazindol)
Number of subjects: 50
Study 775265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 30649711 — intervention group
Group type: EXPERIMENTAL
Intervention: Riomet® ER Strawberry
Number of subjects: 56
Study 30649711 — intervention group
Group type: EXPERIMENTAL
Intervention: Riomet® ER Grape
Number of subjects: 56
Study 30649711 — intervention group
Group type: COMPARATOR
Intervention: Riomet® Cherry
Number of subjects: 56
Study 30649711 — intervention group
Group type: COMPARATOR
Intervention: Metformin IR crushed tablets
Number of subjects: 56
Study 28762527 — intervention group
Group type: EXPERIMENTAL
Intervention: Eliglustat (9 months initial treatment, followed by 9 months in extension)
Number of subjects: 40
Study 28762527 — intervention group
Group type: COMPARATOR
Intervention: Eliglustat (during 9-month open-label period for placebo group)
Number of subjects: 40
Study 25209598 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 14264
Study 25209598 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 14264
Study 25209598 — intervention group
Group type: COMPARATOR
Intervention: Rivaroxaban vs. Warfarin
Number of subjects: 14264
Study 23735473 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg BID
Number of subjects: 56
Study 23735473 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel 10 mg OD
Number of subjects: 56
Study 21219403 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanic acid (amoxiclav)
Number of subjects: 12
Study 21219403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 18046564 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasonography (USG)
Number of subjects: 120
Study 18046564 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler ultrasonography (USG)
Number of subjects: 120
Study 16798773 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.25% 0.75 ml kg(‐1) with tramadol 2 mg kg(‐1) (Group BT2)
Number of subjects: 80
Study 16798773 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine 0.25% 0.75 ml kg(‐1) (Group B)
Number of subjects: 80
Study 16798773 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.25% 0.75 ml kg(‐1) with tramadol 1 mg kg(‐1) (Group BT1)
Number of subjects: 80
Study 16798773 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.25% 0.75 ml kg(‐1) with tramadol 1.5 mg kg(‐1) (Group BT1.5)
Number of subjects: 80
Study 12780360 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular scratchcard gambling
Number of subjects: 12222
Study 12780360 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential problematic scratchcard gambling
Number of subjects: 12222
Study 12780360 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathological scratchcard gambling (PSG)
Number of subjects: 12222
Study 12780360 — intervention group
Group type: EXPERIMENTAL
Intervention: Unique PSG
Number of subjects: 12222
Study 12780360 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined PSG
Number of subjects: 12222
Study 12780360 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic characteristics of combined PSG
Number of subjects: 12222
Study 12780360 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic characteristics of unique PSG
Number of subjects: 12222
Study 11079528 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg x kg(‐1) body mass)
Number of subjects: 8
Study 11079528 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (9 mg x kg(‐1) body mass)
Number of subjects: 8
Study 11079528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 9354537 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose sotalol (80 mg twice daily)
Number of subjects: 255
Study 9354537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 9354537 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose sotalol
Number of subjects: 255
Study 8222651 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged regimen (9 weeks on, 1 week off)
Number of subjects: 294
Study 8222651 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (3 weeks on, 1 week off)
Number of subjects: 294
Study 8222651 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged regimen
Number of subjects: 294
Study 8222651 — intervention group
Group type: EXPERIMENTAL
Intervention: Women already using OC
Number of subjects: 294
Study 8222651 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 294
Study 3759774 — intervention group
Group type: COMPARATOR
Intervention: Unloaded exercise tests (first and last test)
Number of subjects: 6
Study 3759774 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive loading (33, 57, and 73 cm H2O X l‐1 X s) during exercise tests
Number of subjects: 6
Study 30922544 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental skills training
Number of subjects: 38
Study 30922544 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mental skills training)
Number of subjects: 38
Study 30111163 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐ and Family Management Intervention (SAFMI)
Number of subjects: 41
Study 30111163 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 41
Study 27048282 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-initiated intervention program
Number of subjects: 308
Study 27048282 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 308
Study 25002239 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone short message reminder
Number of subjects: 703
Study 25002239 — intervention group
Group type: COMPARATOR
Intervention: Usual appointment track (Control)
Number of subjects: 703
Study 23461152 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue light filtering lens
Number of subjects: 99
Study 23461152 — intervention group
Group type: COMPARATOR
Intervention: Lens without blue light filter
Number of subjects: 99
Study 23461152 — intervention group
Group type: EXPERIMENTAL
Intervention: Own transparent lens
Number of subjects: 99
Study 20226143 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese herbal medicine (TCHM) plus chemotherapy
Number of subjects: 220
Study 20226143 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only (non-TCHM group)
Number of subjects: 220
Study 20226143 — intervention group
Group type: EXPERIMENTAL
Intervention: TCHM treatment in late stage patients
Number of subjects: 220
Study 20226143 — intervention group
Group type: EXPERIMENTAL
Intervention: TCHM treatment with radical resection and chemotherapy
Number of subjects: 220
Study 20226143 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only with radical resection and chemotherapy (non-TCHM group)
Number of subjects: 220
Study 17715033 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodic tamoxifen treatment
Number of subjects: 109
Study 17715033 — intervention group
Group type: EXPERIMENTAL
Intervention: Consecutive tamoxifen treatment
Number of subjects: 109
Study 15209316 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected motivational music
Number of subjects: 27
Study 15209316 — intervention group
Group type: COMPARATOR
Intervention: White noise
Number of subjects: 27
Study 15209316 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior Exposure (music or white noise before task)
Number of subjects: 27
Study 15209316 — intervention group
Group type: EXPERIMENTAL
Intervention: Half Exposure (music or white noise during task for half the duration)
Number of subjects: 27
Study 15209316 — intervention group
Group type: EXPERIMENTAL
Intervention: Full Exposure (music or white noise during entire task)
Number of subjects: 27
Study 11519931 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispositional self-control
Number of subjects: 0